Fidelity Investments’s Indaptus Therapeutics INDP Stock Holding History

Fidelity Investments’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10	Closed	-$105	–	5480
2025 Q2	$105	Buy	+10	New	+$117	﹤0.01%	5134
2024 Q3	–	Sell	-3	Closed	-$167	–	5612
2024 Q2	$167	Buy	+3	New	+$199	﹤0.01%	4938

Other funds holding INDP

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Fidelity Investments's INDP Position: Q3 2025 in Review

Fidelity Investments sold out of Indaptus Therapeutics (INDP) in Q3 2025, closing a stake of 10 shares — an estimated $105 sold.

Fidelity Investments first reported a position in INDP in Q2 2024 and held it in 2 quarters. The position peaked at $167 in Q2 2024. 5 funds tracked by Wall St. Rank hold INDP as of Q3 2025.

Fidelity Investments reported no remaining Indaptus Therapeutics position as of Q3 2025 after selling out during the quarter.
Fidelity Investments sold 10 Indaptus Therapeutics shares in Q3 2025, an estimated $105.
Fidelity Investments first reported a position in Indaptus Therapeutics in Q2 2024 and held it in 2 quarters.
Fidelity Investments's Indaptus Therapeutics position peaked at $167 in Q2 2024.
5 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.